MoneyWorks4Me

Triochem Products submits copy of statement of deviation or variation

14 Oct 2016 Evaluate

Triochem Products has submitted a copy of the statement of deviation or variation in public issue, rights issue, preferential issue, etc. under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..